{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:21:46Z","timestamp":1788870106558,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002261","name":"RFBR-OBR","doi-asserted-by":"publisher","award":["09-04-13851"],"award-info":[{"award-number":["09-04-13851"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"RFBR-ofi_m","doi-asserted-by":"publisher","award":["09-04-1210"],"award-info":[{"award-number":["09-04-1210"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"RFBR-ofi_m","doi-asserted-by":"publisher","award":["11-04-12121"],"award-info":[{"award-number":["11-04-12121"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"RFBR-CNRS","doi-asserted-by":"publisher","award":["07-04-92173"],"award-info":[{"award-number":["07-04-92173"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"RFBR-CNRS","doi-asserted-by":"publisher","award":["10-04-93108"],"award-info":[{"award-number":["10-04-93108"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"RFBR-KOMFI","doi-asserted-by":"publisher","award":["13-04-40375-N"],"award-info":[{"award-number":["13-04-40375-N"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programs of the Russian Academy of Sciences \u201cBasic Sciences for Medicine\u201d"},{"name":"French Ministry of National Education and Science"},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["2011-1.4-514-075"],"award-info":[{"award-number":["2011-1.4-514-075"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jns.2014.03.028","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T19:14:57Z","timestamp":1395515697000},"page":"198-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism"],"prefix":"10.1016","volume":"340","author":[{"given":"Elena A.","family":"Kozina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara R.","family":"Khakimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly G.","family":"Khaindrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriayn G.","family":"Kucheryanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda E.","family":"Vorobyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey N.","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia G.","family":"Georgieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidiya","family":"Kerkerian-Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Ugrumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.03.028_bb0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2014.03.028_bb0010","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2014.03.028_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1353-8020(98)00012-1","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"4","author":"Ehringer","year":"1998","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2014.03.028_bb0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0031-6997(25)07154-6","article-title":"Dopamine (3-hydroxytyramine) and brain function","volume":"18","author":"Hornykiewicz","year":"1966","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jns.2014.03.028_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/newbio245150a0","article-title":"Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat","volume":"245","author":"Agid","year":"1973","journal-title":"Nat New Biol"},{"key":"10.1016\/j.jns.2014.03.028_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/nbdi.1997.0157","article-title":"Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from animal model of parkinsonism","volume":"4","author":"Zigmond","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2014.03.028_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0301-0082(98)00006-9","article-title":"Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach","volume":"55","author":"Bezard","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2014.03.028_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(03)00038-9","article-title":"Pre-symptomatic compensation in Parkinson's disease is not dopamine-mediated","volume":"26","author":"Bezard","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2014.03.028_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2006.07.004","article-title":"The globus pallidus pars externa and Parkinson's disease. Ready for prime time?","volume":"202","author":"Obeso","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2014.03.028_bb0050","series-title":"Parkinson's disease: molecular and therapeutic insights from model systems","first-page":"3","article-title":"Clinical aspects of Parkinson's disease","author":"Fahn","year":"2008"},{"key":"10.1016\/j.jns.2014.03.028_bb0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.1090349","article-title":"Looking backward to move forward: early detection of neurodegenerative disorders","volume":"302","author":"DeKosky","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jns.2014.03.028_bb0060","series-title":"Handbook of neurochemistry and molecular neurobiology","first-page":"21","article-title":"Brain neurons partly expressing monoaminergic phenotype: distribution, development, and functional significance in norm and pathology","author":"Ugrumov","year":"2008"},{"key":"10.1016\/j.jns.2014.03.028_bb0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2011.03.007","article-title":"Modeling of presymptomatic and symptomatic stages of parkinsonism in mice","volume":"181","author":"Ugrumov","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2014.03.028_bb0070","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0028-3908(85)90090-5","article-title":"Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs","volume":"24","author":"Hefti","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2014.03.028_bb0080","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1523\/JNEUROSCI.07-06-01648.1987","article-title":"Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage","volume":"7","author":"Stachowiak","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2014.03.028_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)91656-2","article-title":"Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL\/6 mice: a model for Parkinson's disease","volume":"528","author":"Sundstrom","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0090","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1046\/j.1471-4159.1995.64052080.x","article-title":"NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions","volume":"64","author":"Richard","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1096-9861(20000918)425:2<167::AID-CNE1>3.0.CO;2-K","article-title":"Tyrosine hydroxylase-expressing and\/or aromatic L-amino acid decarboxylase-expressing neurons in the mediobasal hypothalamus of perinatal rats: differentiation and sexual dimorphism","volume":"425","author":"Balan","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jns.2014.03.028_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00429-010-0290-9","article-title":"Vasopressinergic neurons of the supraoptic nucleus in perinatal rats: reaction to osmotic stimulation and its regulation","volume":"215","author":"Abramova","year":"2011","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.jns.2014.03.028_bb0105","series-title":"Methods in neurosciences. Quantitative and qualitative microscopy","first-page":"208","article-title":"Image analytic techniques for quantification of immunohistochemical staining in the nervous system","author":"Smolen","year":"1990"},{"key":"10.1016\/j.jns.2014.03.028_bb0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","article-title":"Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism","volume":"311","author":"Markey","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jns.2014.03.028_bb0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(98)00986-X","article-title":"Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry","volume":"812","author":"Nakazato","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01244661","article-title":"In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain","volume":"34","author":"Carlsson","year":"1973","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2014.03.028_bb0125","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.jns.2014.03.028_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00429-008-0197-x","article-title":"The influence of catecholamine on the migration of gonadotropin-releasing hormone-producing neurons in the rat foetuses","volume":"213","author":"Izvolskaia","year":"2009","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.jns.2014.03.028_bb0135","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0021-9258(19)75212-0","article-title":"Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis","volume":"252","author":"Cleveland","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2014.03.028_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0361-9230(84)90128-X","article-title":"Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: a topographical study","volume":"13","author":"Arluison","year":"1984","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jns.2014.03.028_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1134\/S1054661810030119","article-title":"Automating extraction and analysis of dopaminergic axon terminals in images of frontal slices of the striatum","volume":"20","author":"Gurevich","year":"2010","journal-title":"Pattern Recognit Image Anal"},{"key":"10.1016\/j.jns.2014.03.028_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01246353","article-title":"Choline acetyltransferase and calcitonin gene-related peptide immunoreactivity in motoneurons after different types of nerve injury","volume":"22","author":"Borke","year":"1993","journal-title":"J Neurocytol"},{"key":"10.1016\/j.jns.2014.03.028_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0169-328X(94)00288-P","article-title":"Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum","volume":"30","author":"Lucas","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00726-006-0405-z","article-title":"Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei","volume":"34","author":"Taranukhin","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.jns.2014.03.028_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-079X.2009.00704.x","article-title":"Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats","volume":"47","author":"Chang","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(88)90786-0","article-title":"Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies","volume":"90","author":"Mori","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2014.03.028_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.jns.2014.03.028_bb0180","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/bbrc.1998.8986","article-title":"Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice","volume":"248","author":"Mitsumoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jns.2014.03.028_bb0185","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1523\/JNEUROSCI.18-15-05614.1998","article-title":"Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease","volume":"18","author":"Ho","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2014.03.028_bb0190","doi-asserted-by":"crossref","first-page":"845618","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.jns.2014.03.028_bb0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?","volume":"24","author":"German","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2014.03.028_bb0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","article-title":"Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice","volume":"14","author":"Rousselet","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2014.03.028_bb0205","series-title":"Parkinson's disease: molecular and therapeutic insights from model systems","first-page":"35","article-title":"Neuropathology of Parkinson's disease","author":"Petrucelli","year":"2008"},{"key":"10.1016\/j.jns.2014.03.028_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02337479","article-title":"The hypothalamus in Parkinson disease","volume":"8","author":"Sandyk","year":"1987","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.jns.2014.03.028_bb0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0220","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jns.2014.03.028_bb0225","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin\u2013proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2014.03.028_bb0230","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0235","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.2008.05651.x","article-title":"Modeling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid","volume":"107","author":"Alvarez-Fischer","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1023\/A:1020989812576","article-title":"Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray","volume":"27","author":"Mandel","year":"2002","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jnr.20114","article-title":"Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway","volume":"76","author":"Jakowec","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0250","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neures.2007.10.005","article-title":"Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease","volume":"60","author":"Liu","year":"2008","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(90)90389-L","article-title":"Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study","volume":"38","author":"Javoy-Agid","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2014.03.028_bb0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(93)91005-D","article-title":"Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease","volume":"606","author":"Kastner","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0265","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1471-4159.1993.tb02166.x","article-title":"Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography","volume":"2","author":"Blanchard","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0169-328X(92)90045-D","volume":"13","author":"Pasinetti","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0275","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","article-title":"Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis","volume":"239","author":"Nagatsu","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2014.03.028_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)27006-9","article-title":"Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart","volume":"148","author":"Levitt","year":"1965","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2014.03.028_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)32511-5","article-title":"The site of dopamine formation in rat striatum after L-dopa administration","volume":"217","author":"Hefti","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2014.03.028_bb0290","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0006-8993(93)90414-I","article-title":"Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases","volume":"600","author":"Joyce","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2014.03.028_bb0295","first-page":"1703","article-title":"Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects","volume":"38","author":"Kim","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jns.2014.03.028_bb0300","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1471-4159.1998.70010179.x","article-title":"In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions","volume":"70","author":"Hoffman","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0305","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","article-title":"Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls","volume":"123","author":"Eisensehr","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jns.2014.03.028_bb0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","article-title":"Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse","volume":"12","author":"Araki","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jns.2014.03.028_bb0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1471-4159.2003.01843.x","article-title":"Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc","volume":"86","author":"Stanic","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0320","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1471-4159.2005.03610.x","article-title":"Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates","volume":"96","author":"McCallum","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0091-3057(98)00246-9","article-title":"Effect of the dopaminergic neurotoxin MPTP on cocaine-induced locomotor sensitization","volume":"63","author":"Itzhak","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jns.2014.03.028_bb0330","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2014.03.028_bb0335","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1046\/j.1471-4159.2003.02104.x","article-title":"\u201cPassive stabilization\u201d of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat","volume":"87","author":"Bergstrom","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0340","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1471-4159.2008.05268.x","article-title":"Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates","volume":"105","author":"Perez","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0345","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)30363-0","article-title":"The neurochemistry of Parkinson's disease: effect of L-dopa therapy","volume":"195","author":"Lloyd","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2014.03.028_bb0350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0009-8981(77)90193-0","article-title":"Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain","volume":"75","author":"Nagatsu","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jns.2014.03.028_bb0355","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3565(25)13058-9","article-title":"Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals","volume":"253","author":"Snyder","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2014.03.028_bb0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-4159.2004.02471.x","article-title":"In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats","volume":"90","author":"Sarre","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.03.028_bb0365","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/WNR.0b013e32832984d6","article-title":"Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice","volume":"20","author":"Kirchhoff","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.jns.2014.03.028_bb0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-004-0952-x","article-title":"Axonal transport defects: a common theme in neurodegenerative diseases","volume":"109","author":"Roy","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jns.2014.03.028_bb0375","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1073\/pnas.0611231104","article-title":"1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C","volume":"104","author":"Morfini","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2014.03.028_bb0380","doi-asserted-by":"crossref","first-page":"12776","DOI":"10.1523\/JNEUROSCI.3463-09.2009","article-title":"Axonal transport defects in neurodegenerative diseases","volume":"29","author":"Morfini","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2014.03.028_bb0385","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1073\/pnas.0611227104","article-title":"1-Methyl-4-phenylpyridinium induces synaptic dysfunction through a pathway involving caspase and PKC delta enzymatic activities","volume":"104","author":"Serulle","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2014.03.028_bb0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/syn.20089","article-title":"Selective alterations of gene expression in mice induced by MPTP","volume":"55","author":"Xu","year":"2005","journal-title":"Synapse"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:43:14Z","timestamp":1758382994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":78,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0022510X14001725"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.03.028","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}